CB2R activation ameliorates myocardial fibrosis by accelerating Nrf2 translocation into the nucleus and suppressing the TGF-beta1/Smad3 pathway in a Nrf2-dependent manner [42]. This evidence concerns the gene NFE2L2 and Myocardial fibrosis.